Medicus Pharma Ltd. Commo... (MDCX)
NASDAQ: MDCX
· Real-Time Price · USD
5.20
0.61 (13.29%)
At close: May 12, 2025, 11:25 AM
Company Description
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.
Medicus Pharma Ltd. Common Stock
| Country | CA |
| IPO Date | Nov 15, 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | n/a |
| CEO | Dr. Raza Bokhari M.B.A., M.D., MBA |
Contact Details
Address: 300 Conshohocken State Rd. Suite 200 W. Conshohocken, CA | |
| Website | https://medicuspharma.com/ |
Stock Details
| Ticker Symbol | MDCX |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001997296 |
| CUSIP Number | n/a |
| ISIN Number | CA58471K2020 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Raza Bokhari M.B.A., M.D., MBA | Chief Executive Officer & Executive Chairman |
| Carolyn Bonner | President |
| Dr. Edward J. Brennan Jr., F.A.C.S., FACS, M.D. | Chief Scientific Officer and Head of R&D Program |
| Dr. Faisal Mehmud M.D. | Chief Medical Officer |
| Maryann Adesso | Chief of Staff |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 05, 2025 | 424B3 | Filing |
| May 05, 2025 | 253G2 | Filing |
| May 05, 2025 | 8-K | Current Report |
| Apr 30, 2025 | 10-K/A | [Amend] Annual Report |
| Apr 28, 2025 | 253G2 | Filing |
| Apr 28, 2025 | 424B3 | Filing |
| Apr 28, 2025 | 8-K | Current Report |
| Apr 10, 2025 | QUALIF | Filing |
| Apr 04, 2025 | 1-A POS | Filing |
| Apr 04, 2025 | POS AM | Filing |